Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice
暂无分享,去创建一个
R. Dantzer | V. Poli | R. Bluthé | B. Michaud
[1] R. Dantzer,et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats , 1999, Psychoneuroendocrinology.
[2] C. Dinarello. Cytokines as endogenous pyrogens. , 1999, The Journal of infectious diseases.
[3] M. Herkenham,et al. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat , 1999, Journal of Neuroimmunology.
[4] C. Plata-salamán. Brain mechanisms in cytokine-induced anorexia , 1999, Psychoneuroendocrinology.
[5] R. Dantzer,et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. , 1998, European cytokine network.
[6] P. Mackowiak,et al. Concepts of fever. , 1998, Archives of internal medicine.
[7] R. Dantzer,et al. Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.
[8] A. Dunn,et al. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism , 1998, Neurochemistry International.
[9] T. Lennie. Relationship of body energy status to inflammation-induced anorexia and weight loss , 1998, Physiology & Behavior.
[10] J. Krueger,et al. Vagotomy Blocks the Induction of Interleukin-1β (IL-1β) mRNA in the Brain of Rats in Response to Systemic IL-1β , 1998, The Journal of Neuroscience.
[11] R. Dantzer,et al. Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[12] C. Dinarello,et al. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.
[13] P. Musiani,et al. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. , 1997, The American journal of pathology.
[14] D. Golenbock,et al. Characterization of proinflammatory cytokine production and CD14 expression by murine alveolar macrophage cell lines , 1997, In Vitro Cellular & Developmental Biology - Animal.
[15] N. Rothwell,et al. Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions: the role of cytokines , 1997, British journal of pharmacology.
[16] S. Yamamoto,et al. Primary structure of rat CD14 and characteristics of rat CD14, cytokine, and NO synthase mRNA expression in mononuclear phagocyte system cells in response to LPS , 1997, Journal of leukocyte biology.
[17] R. Dantzer,et al. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice , 1997, Psychoneuroendocrinology.
[18] A. Koj. Initiation of acute phase response and synthesis of cytokines. , 1996, Biochimica et biophysica acta.
[19] R. Dantzer,et al. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. , 1996, Neuroreport.
[20] C. Sweep,et al. Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1ß, TNFα and IL-6: A dose response study , 1996 .
[21] V. Poli,et al. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.
[22] L. Leon,et al. Cytokines and fever. , 1995, Neuroimmunomodulation.
[23] F. Holsboer,et al. Soluble interleukin‐6 (IL‐6) receptor augments central effects of IL‐6 in vivo , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] R. Dantzer,et al. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats , 1995, Brain Research.
[25] N. Rothwell,et al. Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.
[26] N. Rothwell,et al. Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.
[27] R. Dantzer,et al. Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice , 1994, Psychoneuroendocrinology.
[28] R. Dantzer,et al. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.
[29] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[30] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[31] G. Strassmann,et al. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. , 1993, Cytokine.
[32] J. Abrams,et al. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. , 1993, Endocrinology.
[33] W. Zhong,et al. Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. , 1993, Archives of surgery.
[34] M. Brouns,et al. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.
[35] C. Dinarello,et al. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells , 1991, Brain Research.
[36] N. Rothwell,et al. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. , 1991, Canadian journal of physiology and pharmacology.
[37] P. Ghezzi,et al. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. , 1990, The Journal of infectious diseases.
[38] A. Waage,et al. Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo , 1989 .
[39] S. Rosenberg,et al. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. , 1989, Journal of immunology.
[40] H. Baumann,et al. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. , 1989, Journal of immunology.
[41] B. Hazenberg,et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. , 1988, Biochemical and biophysical research communications.
[42] P. Sehgal,et al. Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation , 1986, Cell.
[43] B. Beutler,et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.
[44] R. Dantzer,et al. Mechanisms of the behavioural effects of cytokines. , 1999, Advances in experimental medicine and biology.
[45] V. Poli. IL-6 Unique Functions in Inflammation, Bone Metabolism, and B-Cell Neoplasias Revealed by Studies on IL-6-Deficient Mice , 1998 .
[46] R. Dantzer,et al. Cytokine Actions on Behavior , 1996 .
[47] T. Bártfai,et al. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. , 1993, Brain research.
[48] R. Dantzer,et al. Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.
[49] R. Dantzer,et al. Interleukin-1 receptor antagonist blocks effects of IL-1α and IL-1β on social behaviour and body weight in mice , 1991 .
[50] J. Dayer,et al. Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6. , 1991, European cytokine network.
[51] R. Nordan,et al. Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. , 1988, Lymphokine research.
[52] C. Saper,et al. Regional induction of tumor necrosis factor ar expression in the mouse brain after systemic lipopolysaccharide administration , 2022 .